首页> 外国专利> METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL)

METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL)

机译:预测非典型神经脂基喹哌酮(血清型)精神分裂症患者的疗效的方法

摘要

FIELD: medicine, laboratory diagnostics.;SUBSTANCE: before prescribing quetiapin, it is necessary to conduct immunological studying in patients and at the content of natural killers (CD16+)0.15x109/l and more, IgA concentration in blood serum being 2.50 g/l and less one should predict positive dynamics of therapy with atypical neuroleptic quetiapin (seroquel). The innovation enables to elaborate prognostic criteria for therapeutic efficiency in schizophrenia-suffering patients with atypical neuroleptic quetiapin (seroquel) and carry out rehabilitation of pharmacological measures purposefully.;EFFECT: higher accuracy and efficiency of prediction.;3 ex, 3 tbl
机译:领域:医学,实验室诊断。;物质:处方喹硫平之前,有必要对患者进行免疫学研究,并以自然杀手(CD16 + )0.15x10 9 / l或更高,血清中的IgA浓度为2.50 g / l或更低,应预示非典型抗精神病药物喹硫平(seroquel)的积极作用。这项创新技术能够为患有精神分裂症的非典型抗精神病药物喹硫平(seroquel)的患者制定疗效的预后标准,并有目的地进行药理学治疗;效果:更高的预测准确性和效率; 3 ex,3 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号